Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > Devices & Diagnostics Letter > BioMerieux Warned Over CAPA, Rework Procedures

Devices & Diagnostics Letter

Sept. 17, 2012 | Vol. 39 No. 37

BioMerieux Warned Over CAPA, Rework Procedures

The FDA has warned BioMerieux for several violations related to rework procedures and corrective and preventive actions (CAPA) for its microbial detection systems.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

Related Articles

TCM Warned Over Lax Supplier Controls, GMPs FDA 483 Notes ‘Melted,’ Smelly ECGs at Mortara Impact Instrumentation Form 483 Details Quality Control Issues Aerscher Diagnostics Gets Warning for CAPA, Quality Audit Violations

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.